ZURICH, April 24 Two days after announcing a radical overhaul of its structure, Novartis posted first-quarter profit that beat expectations boosted by an exceptional gain from the sale of its blood transfusion test unit.
The Swiss company said first-quarter net profit jumped 24 percent to $2.968 billion, beating the mean estimate of $2.7 billion in a Reuters poll. Net sales inched up 1 percent to $14.022 billion, compared to the average estimate of $14.246 billion.
The drugmaker's first-quarter results come two days after it announced deals worth over $25 billion to simplify its structure, strengthen its cancer portfolio and exit underperforming businesses. (Reporting by Caroline Copley)
Greece needs reforms, not debt relief - Germany's Schaeuble
BERLIN, Dec 4 Structural reforms rather than debt relief will help Greece to achieve sustainable growth and stay in the euro zone because rates and repayment are putting hardly any burden on its budget, Gerany's finance minister was quoted as saying on Sunday.
UPDATE 2-Trump targets another company, draws Sanders' criticism
WASHINGTON, Dec 3 President-elect Donald Trump drew a rebuke from former Democratic presidential candidate Bernie Sanders on Saturday, after turning his attention to another Indiana company planning a move to Mexico.